Skip to main content

Table 2 Outcomes of enterococcal bloodstream infection in the VSE and VRE BSI groups

From: Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study

 

Total (n=91)

VSE BSI (n=67)

VRE BSI (n=24)

P-value

7-day clinical treatment failure

30 (33.0)

18 (26.9)

12 (50.0)

0.040

7-day microbiologic failure

12 (13.2)

8 (11.9)

4 (16.7)

0.499

Mortality

    

  Attributable mortality

10 (11.0)

6 (9.0)

4 (16.7)

0.447

  Crude mortality

21 (23.9)

15 (22.7)

6 (27.3)

0.059

  1. Data are presented as n (%). Abbreviations: BSI bloodstream infection, VRE vancomycin-resistant enterococci, VSE vancomycin-susceptible enterococci.